The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
What Is Mounjaro 12.5 mg?
Mounjaro 12.5 mg is an escalated dose of tirzepatide, a prescription-only weight management injection licensed in the UK. At 12.5 mg, you're near the maximum therapeutic dose — this level is typically reached after several weeks of gradual dose titration starting from 2.5 mg. The 12.5 mg dose represents a higher concentration of the active ingredient and may be associated with stronger appetite suppression effects, though individual responses vary significantly. If you're prescribed Mounjaro, your healthcare provider will assess whether reaching this dose is appropriate for your health profile. Use our free GLP-1 weight loss calculator to explore projected outcomes at different doses.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Mounjaro 12.5 mg Dose Titration Schedule
Mounjaro dosing follows a structured escalation plan, with each dose increase separated by at least 4 weeks. The 12.5 mg dose is typically reached in week 17 or later of treatment, following this standard schedule:
- Weeks 1–4: 2.5 mg starting dose
- Weeks 5–8: 5 mg escalation
- Weeks 9–12: 7.5 mg escalation
- Weeks 13–16: 10 mg escalation
- Weeks 17–20: 12.5 mg escalation
- Week 21+: 15 mg maximum dose (if tolerated and clinically appropriate)
Not every person reaches 12.5 mg or higher — your prescriber may maintain you at a lower dose if you experience significant side effects or achieve your weight loss goals earlier. Each KwikPen contains 4 weekly injections, and doses are administered once weekly by subcutaneous injection into the abdomen, thigh, or upper arm.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Weight Loss Potential and Side Effects at 12.5 mg
Clinical trial data shows that higher Mounjaro doses are associated with greater average weight loss — at the 15 mg maximum dose, participants lost approximately 20.9% of body weight over 72 weeks alongside lifestyle changes. The 12.5 mg dose sits between the 10 mg dose (approximately 19.5% average loss) and the maximum 15 mg dose. However, individual results vary significantly based on adherence, diet, physical activity, and metabolism.
At higher doses, gastrointestinal side effects (nausea, diarrhoea, constipation, vomiting) are more common. Most people find these effects manageable and reduce over time. If you experience severe or persistent side effects at 12.5 mg, your prescriber may reduce you to a lower maintenance dose. Track your progress with our free progress tracker to monitor both weight loss and how you feel on your dose.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
How quickly do you reach the 12.5 mg Mounjaro dose?
You reach 12.5 mg in approximately week 17–20 of treatment, following standard dose titration (increasing every 4 weeks starting from 2.5 mg). The gradual escalation allows your body to adjust and helps your prescriber identify the optimal dose for you. Some people may take longer if doses are delayed due to side effects or clinical reasons.
Is 12.5 mg the maximum dose of Mounjaro?
No. 12.5 mg is an escalated dose, but the maximum licensed dose is 15 mg once weekly. Your prescriber may increase you from 12.5 mg to 15 mg in week 21 or later if clinically appropriate and you tolerate the medication well. Some people maintain 12.5 mg as their effective maintenance dose.
What's the difference between Mounjaro 12.5 mg and Wegovy at maximum dose?
Mounjaro 12.5 mg and Wegovy 2.4 mg are not directly comparable — they are different medications with different mechanisms. Mounjaro is a dual GIP and GLP-1 receptor agonist; Wegovy is a GLP-1 agonist only. Both require UK prescription and clinical assessment. Ask your prescriber which is more suitable for your individual health profile.
Will I lose more weight on 12.5 mg than lower doses?
Higher doses are generally associated with greater average weight loss in clinical trials, but individual results vary considerably. Some people achieve their weight loss goals on lower doses and choose to stay there, whilst others benefit from escalating to higher doses. Your prescriber will personalise your treatment based on your progress and tolerance.
What should I do if I experience side effects at 12.5 mg?
Contact your prescriber immediately if side effects are severe or intolerable. Common side effects (nausea, diarrhoea) often improve over time, but your prescriber may reduce your dose to a lower maintenance level or pause escalation. Never adjust your dose without medical guidance — your Mounjaro KwikPen should only be used as prescribed.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.